NewsBenzingaLake Street avvia la copertura su C4 Therapeutics con rating Buy, annuncia un prezzo obiettivo di 11 dollari Lake Street avvia la copertura su C4 Therapeutics con rating Buy, annuncia un prezzo obiettivo di 11 dollari Benzinga 2026.10.28 23:14 (GMT+0) Open on Benzinga Other news Visa: Stablecoin Settlement Annualized Volume Tops $25 Billion, Up 10x Year-over-Year Alphabet, Microsoft, ServiceNow, Lumentum Holdings and Oracle: Why These 5 Stocks Are on Investors' Radars Today Elon Musk vs. Tesla? His Midterm Money Could Work Against His Own Cars CTO Realty Growth, Inc. (CTO) Q3 2026 Earnings Call Transcript Regional Management Corp. (RM) Q3 2026 Earnings Call Transcript See the Trump Administration Stock Portfolio That Spans More Than 40 Companies
Alphabet, Microsoft, ServiceNow, Lumentum Holdings and Oracle: Why These 5 Stocks Are on Investors' Radars Today